» Articles » PMID: 34073560

Current Search Through Liquid Biopsy of Effective Biomarkers for Early Cancer Diagnosis into the Rich Cargoes of Extracellular Vesicles

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jun 2
PMID 34073560
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

There exist many different human cancers, but regardless of the cancer type, an early diagnosis is a necessary condition for further optimal outcomes from the disease. Therefore, efficient specific and sensitive cancer biomarkers are urgently needed. This is especially true for the cancers depicting a silent progression, and those only diagnosed in an already metastatic state with a poor survival prognostic. After a rapid overview of the previous methods for cancer diagnosis, the outstanding characteristics of extracellular vesicles (EVs) will be presented, as new interesting candidates for early cancer diagnosis in human biofluid non-invasive liquid biopsy. The present review aims to give the state-of-the-art of the numerous searches of efficient EV-mediated cancer diagnosis. The corresponding literature quest was performed by means of an original approach, using a powerful Expernova Questel platform, which was specifically adapted for a literature search on EVs. The chosen collected scientific papers are presented in two parts, the first one drawing up a picture of the current general status of EV-mediated cancer diagnosis and the second one showing recent applications of such EV-mediated diagnosis for six important human-specific cancers, i.e., lung, breast, prostate, colorectal, ovary and pancreatic cancers. However, the promising perspective of finally succeeding in the worldwide quest for the much-needed early cancer diagnosis has to be moderated by the many remaining challenges left to solve before achieving the efficient clinical translation of the constantly increasing scientific knowledge.

Citing Articles

Clinical Impact of Multi-omics profiling of extracellular vesicles in cancer Liquid Biopsy.

Kulkarni M, Kar R, Ghosh S, Sonar S, Mirgh D, Sivakumar I J Liq Biopsy. 2025; 3:100138.

PMID: 40026564 PMC: 11863700. DOI: 10.1016/j.jlb.2024.100138.


Non-Coding RNA as a Biomarker in Lung Cancer.

Suri C, Swarnkar S, Bhaskar L, Verma H Noncoding RNA. 2024; 10(5).

PMID: 39452836 PMC: 11514784. DOI: 10.3390/ncrna10050050.


Identification of ENO-1 positive extracellular vesicles as a circulating biomarker for monitoring of Ewing sarcoma.

Uotani K, Fujiwara T, Ueda K, Yoshida A, Iwata S, Morita T Cancer Sci. 2024; 115(11):3660-3671.

PMID: 39307979 PMC: 11531948. DOI: 10.1111/cas.16343.


Macrophage-derived exosomal miRNA-141 triggers endothelial cell pyroptosis by targeting NLRP3 to accelerate sepsis progression.

Zhan F, Zhang J, He P, Chen W, Ouyang Y Int J Immunopathol Pharmacol. 2024; 38:3946320241234736.

PMID: 38652556 PMC: 11041538. DOI: 10.1177/03946320241234736.


Extracellular Vesicle-DNA: The Next Liquid Biopsy Biomarker for Early Cancer Diagnosis?.

Tatischeff I Cancers (Basel). 2023; 15(5).

PMID: 36900248 PMC: 10000627. DOI: 10.3390/cancers15051456.


References
1.
Niu L, Song X, Wang N, Xue L, Song X, Xie L . Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer. Cancer Sci. 2018; 110(1):433-442. PMC: 6317937. DOI: 10.1111/cas.13862. View

2.
Fang S, Tian H, Li X, Jin D, Li X, Kong J . Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification. PLoS One. 2017; 12(4):e0175050. PMC: 5378374. DOI: 10.1371/journal.pone.0175050. View

3.
An T, Qin S, Sun D, Huang Y, Hu Y, Li S . Unique Protein Profiles of Extracellular Vesicles as Diagnostic Biomarkers for Early and Advanced Non-Small Cell Lung Cancer. Proteomics. 2019; 19(12):e1800160. DOI: 10.1002/pmic.201800160. View

4.
Chang L, Ni J, Zhu Y, Pang B, Graham P, Zhang H . Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression. Theranostics. 2019; 9(14):4130-4140. PMC: 6592165. DOI: 10.7150/thno.34692. View

5.
Li M, Zou X, Xia T, Wang T, Liu P, Zhou X . A five-miRNA panel in plasma was identified for breast cancer diagnosis. Cancer Med. 2019; 8(16):7006-7017. PMC: 6853814. DOI: 10.1002/cam4.2572. View